Screener / SEC EDGAR /CIK 0001169561 /10-K filed May 11, 2026, compared with May 5, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Commvault Systems Inc CVLT

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 44 Form 144 notices for $18.8M

10-Q, 10-K and Form 144
Plans running now 3 Danielle Abrahamsen, Vivie Lee, Sanjay Mirchandani
Plans adopted 16 reported since May 5, 2023 Form 144 notices 44 $18.8M the sellers expected to sell

What CVLT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 18, 2024 to Feb 10, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Danielle Abrahamsen
Chief Accounting Officer
Adopted 10b5-1 plan Feb 17, 2026 10-K May 11, 2026
What the company wrote
On February 17, 2026, Danielle Abrahamsen, Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 6,600 shares of the Company’s common stock. Actual sales will vary due to the achievement of PSUs and shares sold for tax obligations. The plan is in effect until the earlier of February 10, 2027 or the completion of all authorized sales.
Vivie Lee
member of our Board of Directors
Adopted 10b5-1 plan Feb 3, 2026 10-K May 11, 2026
What the company wrote
On February 3, 2026, Vivie Lee, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of 595 shares of the Company’s common stock. The plan is in effect until the earlier of February 3, 2027 or the completion of all authorized sales.
Sanjay Mirchandani
Chief Executive Officer
Adopted 10b5-1 plan Dec 13, 2025 10-Q Jan 28, 2026
What the company wrote
On December 13, 2025, Sanjay Mirchandani, Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 86,000 shares of the Company’s common stock. The plan is in effect until November 18, 2026.
Shane Sanders
member of our Board
Adopted 10b5-1 plan Nov 21, 2025 10-Q Jan 28, 2026
What the company wrote
On November 21, 2025, Shane Sanders, a member of our Board, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of 476 shares of the Company’s common stock. The plan is in effect until August 21, 2026.
Jennifer DiRico
Chief Financial Officer
Adopted 10b5-1 plan Jun 10, 2025 10-Q Jul 30, 2025
What the company wrote
On June 10, 2025, Jennifer DiRico, Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 21,000 shares of the Company’s common stock. The plan is in effect until March 6, 2026.
Allison Pickens
member of our Board of Directors
Adopted 10b5-1 plan Feb 10, 2025 10-K May 5, 2025
What the company wrote
On February 10, 2025, Allison Pickens, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of 2,760 shares of the Company’s common stock. The plan is in effect until June 4, 2026.
Vivie Lee
member of our Board of Directors
Adopted 10b5-1 plan Feb 3, 2025 10-K May 5, 2025
What the company wrote
On February 3, 2025, Vivie Lee, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of 2,333 shares of the Company’s common stock. The plan is in effect until February 3, 2026.
Nicholas Adamo
Chairman of our Board of Directors
Adopted 10b5-1 plan Nov 25, 2024 10-Q Jan 29, 2025
What the company wrote
On November 25, 2024, Nicholas Adamo, Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of 1,500 shares of the Company’s common stock. The plan is in effect until November 25, 2025.
Gary Merrill
Chief Commercial Officer
Adopted 10b5-1 plan Nov 20, 2024 10-Q Jan 29, 2025
What the company wrote
On November 20, 2024, Gary Merrill, Chief Commercial Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 37,000 shares of the Company’s common stock. The plan is in effect until May 29, 2026.
Sanjay Mirchandani
Chief Executive Officer
Adopted 10b5-1 plan Nov 18, 2024 10-Q Jan 29, 2025
What the company wrote
On November 18, 2024, Sanjay Mirchandani, Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 86,000 shares of the Company’s common stock. The plan is in effect until December 31, 2025.
Shane Sanders
member of our Board of Directors
Adopted 10b5-1 plan Nov 14, 2024 10-Q Jan 29, 2025
What the company wrote
On November 14, 2024, Shane Sanders, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 600 shares of the Company’s common stock. The plan is in effect until August 20, 2025.
Gary Merrill
Chief Financial Officer
Ended 10b5-1 plan May 28, 2024 10-Q Jul 31, 2024
What the company wrote
On May 28, 2024, Gary Merrill, Chief Financial Officer, modified his Rule 10b5-1 trading arrangement that was originally adopted on December 4, 2023, to increase the number of shares to be sold under the plan. The modified trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 19,000 shares of the Company’s common stock and is in effect until November 29, 2024.
Allison Pickens
member of our Board of Directors
Adopted 10b5-1 plan Feb 16, 2024 10-K May 13, 2024
What the company wrote
On February 16, 2024, Allison Pickens, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 4,100 shares of the Company’s common stock. The plan is in effect until March 4, 2025.
Vivie Lee
member of our Board of Directors
Adopted 10b5-1 plan Feb 2, 2024 10-K May 13, 2024
What the company wrote
On February 2, 2024, Vivie Lee, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 4,100 shares of the Company’s common stock. The plan is in effect until September 6, 2024.
Nicholas Adamo
Chairman of our Board of Directors
Adopted 10b5-1 plan Feb 1, 2024 10-K May 13, 2024
What the company wrote
On February 1, 2024, Nicholas Adamo, Chairman of our Board of Directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 2,450 shares of the Company’s common stock. The plan is in effect until September 6, 2024.
Gary Merrill
Chief Financial Officer
Adopted 10b5-1 plan Dec 4, 2023 10-Q Jan 31, 2024
What the company wrote
On December 4, 2023, Gary Merrill, Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 13,000 shares of the Company’s common stock. The plan is in effect until November 29, 2024
Sanjay Mirchandani
Chief Executive Officer
Adopted 10b5-1 plan Dec 4, 2023 10-Q Jan 31, 2024
What the company wrote
On December 4, 2023, Sanjay Mirchandani, Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to approximately 86,000 shares of the Company’s common stock. The plan is in effect until December 31, 2024.
James Whalen
Chief Accounting Officer
Ended 10b5-1 plan May 23, 2023 10-Q Aug 1, 2023
What the company wrote
On May 23, 2023, James Whalen, Chief Accounting Officer, terminated a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c), originally adopted on March 2, 2023, for the sale of up to approximately 3,000 shares of the Company’s common stock until August 25, 2023.
Show the other 10 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 5, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Sep 11, 2026 Adamo Nicola
Director
1,530 $201K
Aug 20, 2026 Shenkman Arlen
Director
5,856 $777K
Aug 19, 2026 Merrill Gary
Officer
1,293 $185K
Aug 19, 2026 Abrahamsen Danielle Nicole
Officer
486 $69K
Aug 19, 2026 Mirchandani Sanjay
Officer, Director
6,857 $979K
Aug 18, 2026 Mirchandani Sanjay
Officer, Director
4,840 $695K
Aug 18, 2026 Merrill Gary
Officer
1,854 $266K
Aug 18, 2026 Abrahamsen Danielle Nicole
Officer
391 $56K
Aug 17, 2026 Abrahamsen Danielle Nicole
Officer
119 $17K
Aug 17, 2026 Mirchandani Sanjay
Officer, Director
12,437 $1.8M
Aug 10, 2026 Haydon William Geoffrey
Officer
316 $43K
Aug 10, 2026 Lee Vivie
Director
595 $80K
Aug 10, 2026 Sanders A Shane
Director
476 $64K
Jul 2, 2026 Abrahamsen Danielle Nicole
Officer
254 $38K
May 26, 2026 Merrill Gary
Officer
4,554 $486K
May 26, 2026 Abrahamsen Danielle Nicole
Officer
227 $24K
May 22, 2026 Mirchandani Sanjay
Officer, Director
9,701 $1.0M
May 22, 2026 Merrill Gary
Officer
3,777 $406K
May 22, 2026 Abrahamsen Danielle Nicole
Officer
101 $11K
May 20, 2026 Mirchandani Sanjay
Officer, Director
8,450 $838K
May 20, 2026 Abrahamsen Danielle Nicole
Officer
365 $36K
May 19, 2026 Merrill Gary
Officer
2,275 $237K
May 19, 2026 Mirchandani Sanjay
Officer, Director
6,238 $649K
May 19, 2026 Abrahamsen Danielle Nicole
Officer
169 $18K
May 19, 2026 Abrahamsen Danielle Nicole
Officer
896 $95K
May 19, 2026 Merrill Gary
Officer
2,285 $243K
May 19, 2026 Mirchandani Sanjay
Officer, Director
13,158 $1.4M
May 18, 2026 Abrahamsen Danielle Nicole
Officer
516 $54K
May 18, 2026 Abrahamsen Danielle Nicole
Officer
409 $43K
May 18, 2026 Merrill Gary
Officer
3,098 $324K
May 18, 2026 Mirchandani Sanjay
Officer, Director
8,457 $884K
Mar 17, 2026 Mirchandani Sanjay
Officer, Director
10,052 $805K
Mar 16, 2026 Mirchandani Sanjay
Officer, Director
10,338 $816K
Feb 19, 2026 Merrill Gary
Officer
1,892 $173K
Feb 18, 2026 Merrill Gary
Officer
2,593 $234K
Feb 18, 2026 Abrahamsen Danielle Nicole
Officer
218 $20K
Feb 18, 2026 Mirchandani Sanjay
Officer, Director
6,480 $585K
Dec 3, 2025 ALLISON PICKENS
Director
690 $85K
Nov 19, 2025 GARY D MERRILL
Officer
1,845 $226K
Nov 19, 2025 SANJAY MIRCHANDANI
Officer, Director
13,109 $1.6M
Nov 18, 2025 SANJAY MIRCHANDANI
Officer, Director
7,833 $969K
Nov 17, 2025 JENNIFER DIRICO
OFFICER
806 $102K
Nov 17, 2025 SANJAY MIRCHANDANI
OFFICER, DIRECTOR
6,615 $838K
Nov 17, 2025 GARY MERRILL
OFFICER
2,594 $328K
Show the other 36 notices

From the Form 144 XML filed with the SEC, since Nov 17, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVLT/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.